OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green acquired 18,702 shares of OneMedNet stock in a transaction that occurred on Monday, June 15th. The shares were purchased at an average cost of $0.54 per share, with a total value of $10,099.08. Following the purchase, the chief executive officer owned 1,859,725 shares of the company’s stock, valued at $1,004,251.50. This represents a 1.02% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Aaron Green also recently made the following trade(s):
- On Friday, June 12th, Aaron Green acquired 36,920 shares of OneMedNet stock. The shares were purchased at an average cost of $0.56 per share, with a total value of $20,675.20.
OneMedNet Trading Down 10.2%
Shares of NASDAQ:ONMD opened at $0.50 on Wednesday. The company has a 50 day moving average of $0.86 and a 200 day moving average of $0.95. The stock has a market cap of $27.27 million, a P/E ratio of -10.02 and a beta of 1.12. OneMedNet Corporation has a 12 month low of $0.33 and a 12 month high of $4.22.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. State Street Corp lifted its stake in shares of OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the period. Jane Street Group LLC purchased a new position in OneMedNet during the 4th quarter valued at about $119,000. Virtu Financial LLC purchased a new position in OneMedNet during the 4th quarter valued at about $48,000. HRT Financial LP purchased a new position in OneMedNet during the 4th quarter valued at about $32,000. Finally, Exencial Wealth Advisors LLC lifted its position in OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after acquiring an additional 45,401 shares during the period. Hedge funds and other institutional investors own 0.95% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have weighed in on ONMD. Wall Street Zen cut OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of OneMedNet in a report on Monday, June 1st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, OneMedNet currently has a consensus rating of “Sell”.
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Stories
- Five stocks we like better than OneMedNet
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
